The in vitro and ex vivo antiplatelet effect of TRK-100, a stable prostacyclin analog, in several species.
Open Access
- 1 January 1988
- journal article
- research article
- Published by Elsevier in The Japanese Journal of Pharmacology
- Vol. 47 (1) , 1-10
- https://doi.org/10.1254/jjp.47.1
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesThis publication has 9 references indexed in Scilit:
- Hemodialysis Using Prostacyclin Instead of Heparin as the Sole Antithrombotic AgentNew England Journal of Medicine, 1981
- Carbacyclin — A potent stable prost acyclin analogue for the inhibition of platelet aggregationProstaglandins, 1980
- Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different speciesProstaglandins, 1978
- Chemical stability of prostacyclin (PGI2) in aqueous solutionsProstaglandins, 1978
- EFFECT OF LUNG TRANSIT ON SYSTEMIC DEPRESSOR RESPONSES TO ARACHIDONIC-ACID AND PROSTACYCLIN IN DOGS1978
- Effects of prostacyclin (PGX) on cyclic AMP concentrations in human plateletsProstaglandins, 1977
- Modulation of human platelet adenylate cyclase by prostacyclin (PGX)Prostaglandins, 1977
- FORMATION OF PROSTACYCLIN (PGL2) BY DIFFERENT LAYERS OF ARTERIAL-WALL1977
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976